Markets
News
Analysis
Tools
Learn
Stock
Score
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Start for free
News
All
Editors' Picks
Forex
Commodities
Stocks
Indices
Cryptocurrencies
Technical Analysis
Economic Indicator
Other
Important Only
First Mid Bancshares' Q2 adjusted EPS beats estimates
OverviewFirst Mid Bancshares Q2 adjusted EPS beats analyst expectations, per LSEG dataCompany reports record high net income for Q2 2025Board increases quarterly dividend to $0.25 per shareOutlookCompany focuses on disciplined credit culture amid fluctuating macroeconomic environmentFirst Mid invest...
Reuters
Thu, Jul 24
Integer Holdings beats Q2 sales estimates, raises FY foreacst
OverviewInteger fiscal Q2 sales rise 11% to $476 mln, beating analyst expectationsAdjusted EPS for fiscal Q2 meets analyst estimates, per LSEG dataCompany raises 2025 adjusted operating income and EPS outlook at the midpointOutlookInteger sees 2025 adjusted EPS of $6.25 to $6.51, a growth of 18%-23%...
Reuters
Thu, Jul 24
Sensor maker CTS' Q2 sales rise 4% to $135 mln, beat estimates
OverviewCTS Q2 sales rise 4% yr/yr to $135 mln, beating analyst expectationsAdjusted EPS for Q2 beats analyst expectations, reflecting solid profitabilityCo maintains 2025 guidance for sales and adjusted EPS, indicating confidenceOutlookCTS maintains 2025 sales guidance of $520-$550 mlnCompany expec...
Reuters
Thu, Jul 24
Constellation Energy receives nod from FERC for Calpine acquisition
July 24 (Reuters) - Utility company Constellation Energy CEG.O said on Thursday it has received a regulatory approval from the Federal Energy Regulatory Commission (FERC) for its previously announced $16.4 billion acquisition of Calpine Corporation.This approval represents a step forward in the tran...
Reuters
Thu, Jul 24
Novartis to pay Matchpoint up to $1 billion to develop anti-inflammatory therapies
July 24 (Reuters) - Swiss drugmaker Novartis NOVN.S will pay up to $1 billion to U.S. biotech Matchpoint Therapeutics to develop oral drugs for several inflammatory diseases. Matchpoint said on Thursday it will use its technology to develop drugs that block the activity of a specific protein, helpin...
Reuters
Thu, Jul 24
United Bankshares Q2 EPS beats estimates, driven by Piedmont acquisition
OverviewUnited Bankshares Q2 EPS of $0.85 beats analyst expectationsNet income for Q2 2025 at $120.7 mln, driven by Piedmont acquisitionCo repurchased 981,000 shares under stock buyback planOutlookUnited anticipates continued success in second half of 2025United sees positive impact from Atlanta mar...
Reuters
Thu, Jul 24
Motorola Solutions unveils new features to boost transparency in public safety tech
July 24 (Reuters) - Motorola Solutions said on Wednesday it will introduce AI labels across its safety and security products, in a bid to increase transparency around the use of artificial intelligence in public safety and enterprise security.The move aims to demystify how AI is used in its products...
Reuters
Thu, Jul 24
RPT-BREAKINGVIEWS-Tesla drifts away from benchmark status
By Jonathan Guilford NEW YORK, July 23 (Reuters Breakingviews) - Despite reshaping the car industry, Tesla TSLA.O is becoming even less of an automaker for investment purposes. Uninspiring second-quarter results reinforce the idea that Elon Musk probably will keep driving the $1 trillion company...
Reuters
Thu, Jul 24
RPT-BREAKINGVIEWS-Alphabet’s AI option casts tempting spell
By Jennifer Saba NEW YORK, July 23 (Reuters Breakingviews) - Alphabet GOOGL.O may have three classes of shares, but its value increasingly rests on a tantalizing artificial intelligence option. Google’s parent company unveiled plans on Wednesday to boost capital expenditure this year by 13% alon...
Reuters
Thu, Jul 24
RPT-BREAKINGVIEWS-Big banks audaciously try to thread capital needle
By Stephen Gandel NEW YORK, July 23 (Reuters Breakingviews) - Mega-banks are ready to shrink the capital dam protecting U.S. taxpayers from another financial storm. At a daylong event hosted by Michelle Bowman, the Federal Reserve vice chair of supervision, the consensus was that ultra-protective...
Reuters
Thu, Jul 24
RPT-BREAKINGVIEWS-Trump auto tariff U-turn gives everyone whiplash
By Katrina Hamlin HONG KONG, July 24 (Reuters Breakingviews) - President Donald Trump’s auto tariff U-turn is making everyone carsick. His latest deal cuts U.S. tariffs on Japanese vehicle imports to 15% from a previous total of 27.5%, offering respite to companies that haven’t invested heavily i...
Reuters
Thu, Jul 24
West Pharma raises annual profit forecast on strong demand for its drug components
July 24 (Reuters) - Medical equipment maker West Pharmaceutical WST.N raised its annual profit forecast on Thursday, after topping second-quarter estimates on robust demand for its components used in GLP-1 weight-loss and diabetes drugs as well as a weaker dollar.The Pennsylvania-based firm's sh...
Reuters
Thu, Jul 24
Nasdaq profit beats estimates as volatile markets lift trading volumes
July 24 (Reuters) - Nasdaq NDAQ.O beat Wall Street estimates for second-quarter profit on Thursday, as volatile markets boosted trading volumes while first-half listings on its eponymous exchange hit their highest since 2021.U.S. markets were roiled during the quarter due to President Donald Trump...
Reuters
Thu, Jul 24
S&T Bancorp Q2 net income falls to $31.9 mln
OverviewS&T Bancorp Q2 net income declines to $31.9 mln from $33.4 mln in Q1Net interest income rises 3.90% driven by margin expansion and loan growthAsset quality remains strong; nonperforming assets decrease to $21.3 mlnOutlookCompany remains confident in strategy and future growth opportuniti...
Reuters
Thu, Jul 24
Street View: Analysts eye Viking's oral obesity drug data in second half
** Drug developer Viking Therapeutics VKTX.O late on Wednesday reported a wider second-quarter net loss of $65.6 million, and said it expects to report mid-stage trial results of its oral obesity drug in the second half of the year ** Shares of the company were down 8.2% at $30.65 premarket ALL EYE...
Reuters
Thu, Jul 24
Property services firm FirstService's Q2 revenue up 9%, beats estimates
OverviewFirstService Q2 revenue rises 9% yr/yr, beating analyst expectationsAdjusted EPS for Q2 increases 26%, surpassing analyst estimatesGrowth driven by Residential and Brands segments, aided by acquisitionsOutlookCompany says on track to meet 2025 goals despite macroeconomic uncertaintiesResult ...
Reuters
Thu, Jul 24
Consumer lending firm World Acceptance's Q1 revenue beats estimates
OverviewWorld Acceptance fiscal Q1 revenue rises 2.3%, beating analyst expectationsNet income for fiscal Q1 declines sharply, impacted by credit loss provisionsCo announces $100 mln share repurchase program and redemption of senior notesOutlookCompany expects higher revenue and lower charge-offs in ...
Reuters
Thu, Jul 24
Berkshire Hills' Q2 operating EPS up 25%, margin improves
OverviewBerkshire Hills Q2 operating EPS rises 15% sequentially, 25% yr/yrCompany's net interest margin improves, non-interest expenses decreaseBerkshire preparing merger with Brookline Bancorp, boosting Northeast presenceOutlookCompany expects merger with Brookline Bancorp to close in 2025Berks...
Reuters
Thu, Jul 24
Building products maker HNI's Q2 sales, EPS beats expectations
OverviewHNI Q2 net sales rise 7% to $667.1 mln, beating analyst expectationsAdjusted EPS for Q2 increases 41% to $1.11, exceeding estimatesGrowth driven by volume increases and synergy benefits from Kimball acquisitionOutlookCompany expects Q3 net sales growth in Workplace Furnishings and Residentia...
Reuters
Thu, Jul 24
Novartis to pay Matchpoint up to $1 billion for inflammatory therapies
July 24 (Reuters) - Drugmaker Novartis NOVN.S will pay up to $1 billion to Matchpoint Therapeutics to develop oral drugs for several inflammatory diseases, the private firm said on Thursday.
Reuters
Thu, Jul 24
1
...
296
297
298
299
300
next page
KeyAI
Please log in to use KeyAI
Log in
Start for free